• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Novartis and Pfizer-Backed Mediar Nets $85M for Fibrosis Paradigm Shift

cafead

Administrator
Staff member
  • cafead   Mar 15, 2023 at 11:32: AM
via Backed by an impressive cadre of pharma leaders including Novartis and Pfizer, Mediar Therapeutics added another $85 million to its coffers Wednesday to take its first-in-class fibrosis therapies to the clinic.

article source
 

<